Close Menu
Home › Oncology Trends › Liquid Biopsy

Liquid Biopsy

Biocept Shares Skyrocket on Commercial Launch of Lung Cancer Liquid Biopsy Test

Shares jumped nearly 90 percent today after the firm said this morning that it has commercially launched its Target Selector NGS Lung Panel assay.

Qiagen, Inovio to Develop CDx for Immunotherapy Targeting Precancerous Cervical Lesions

The test will guide clinical decision making related to Inovio's DNA-based immunotherapy to treat cervical dysplasia caused by human papillomavirus.

Personal Genome Diagnostics Alleges Patent Fraud by Guardant Health in Countersuit

PGDx, the defendant in the liquid biopsy IP case, has alleged that Guardant's CEO should have been named as an inventor on patents but was purposefully left off.

OncoCyte Q1 Net Loss Up 2 Percent

The firm is conducting validation studies on its lung cancer test and continues to anticipate commercializing it in the second half of this year.  

Guardant Health Announces Plans for Prospective Colorectal Cancer Screening Study

Premium

During its earnings call this week, the liquid biopsy firm said it is planning a 10,000-patient trial to test its Lunar assay for colorectal cancer screening.

May 09, 2019

Guardant Health Q1 Revenues Swell 120 Percent

May 09, 2019

Natera's Q1 Revenues Climb 7 Percent

May 09, 2019

Hong Kong's Take2 to Commercialize Early Cancer Detection Test; Focus on Healthcare Informatics

Premium
May 08, 2019

Biocept Q1 Revenues Up 27 Percent

May 08, 2019

BillionToOne to Launch Noninvasive Prenatal Screening Test; Plans Liquid Biopsy Products

Premium
May 07, 2019

Genomic Health Q1 Revenues Up 17 Percent

May 06, 2019

Hong Kong Startup Licenses Nasopharyngeal Cancer Early Detection Technology From Grail

May 01, 2019

Exact Sciences Ramps Up Plans for Pipeline Development as Cologuard Market Share Grows

Premium
Apr 30, 2019

Blood-Based Colon Cancer Protein Biomarkers Could Lead to Development of Liquid Biopsy Test

Premium
Apr 30, 2019

Bio-Techne's Fiscal Q3 Revenues Rise 13 Percent

Apr 26, 2019

Inivata Clinical Validation Bolsters Liquid Biopsy Evidence Base, Aids Platform Comparisons

Premium
Apr 23, 2019

Epic Sciences Receives CE Mark for Liquid Biopsy Test Collection Kit

Apr 23, 2019

Biocartis, Covance Sign Commercialization Agreement for Idylla

Apr 23, 2019

OmniSeq, LabCorp Extend Distribution Deal

Apr 16, 2019

U Michigan Researchers Develop Wearable Microfluidic Device for CTC Detection, Monitoring

Premium
Apr 16, 2019

Canaccord Initiates Coverage of Guardant Health With Buy Rating

Apr 12, 2019

OncoCell Targets Cancer Prognostic Space With Phagocyte-Based Collection Technology

Premium
Apr 10, 2019

Georgia Tech, Emory Developing Urine-Based Dx to Guide Cancer Immunotherapies

Premium
Apr 10, 2019

Guardant Health Liquid Biopsy Test to be Covered by EviCore

Apr 04, 2019

Memorial Sloan Kettering Nears Approval for Liquid Biopsy Test; Describes Validation at AACR

Premium
More articles

What's Popular?

In Liquid Biopsy

  1. Biocept Shares Skyrocket on Commercial Launch of Lung Cancer Liquid Biopsy Test

  2. Personal Genome Diagnostics Alleges Patent Fraud by Guardant Health in Countersuit

  3. Qiagen, Inovio to Develop CDx for Immunotherapy Targeting Precancerous Cervical Lesions

  4. OncoCyte Q1 Net Loss Up 2 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.